Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Tesofensine structure

Tesofensine

Metabolic
Phase 2 Research
55%
Moderate Risk
3/5

Dosing Protocol

Typical Dose 0.5 mg
Range 0.25 - 0.5 mg
Maintenance 0.5 mg daily

Pharmacokinetics

Half-Life 9.2 days
Onset 1.0 hrs
Peak 8.0 hrs
Duration 14.0 days
Bioavailability 80%
Primary Route Oral

Administration

Routes Oral
Syringe Type Oral
Timing Morning

Special Instructions

Very long half-life (9+ days) - once daily dosing. Start at lowest dose (0.25mg). Weight loss effects take 2-4 weeks to manifest. Steady state reached in ~6 weeks. NOT FDA approved.